Barreca, F.; Aventaggiato, M.; Cristina, M.; Sansone, L.; Belli, M.; Lista, M.B.; Francisci, G.; Valente, S.; Rotili, D.; Mai, A.;
et al. A Combined SIRT5 Activation and SIRT3 Inhibition Prevents Breast Cancer Spheroids Growth by Reducing HIF-1α and Mitophagy. Pharmaceuticals 2026, 19, 23.
https://doi.org/10.3390/ph19010023
AMA Style
Barreca F, Aventaggiato M, Cristina M, Sansone L, Belli M, Lista MB, Francisci G, Valente S, Rotili D, Mai A,
et al. A Combined SIRT5 Activation and SIRT3 Inhibition Prevents Breast Cancer Spheroids Growth by Reducing HIF-1α and Mitophagy. Pharmaceuticals. 2026; 19(1):23.
https://doi.org/10.3390/ph19010023
Chicago/Turabian Style
Barreca, Federica, Michele Aventaggiato, Mario Cristina, Luigi Sansone, Manuel Belli, Maria Beatrice Lista, Gaia Francisci, Sergio Valente, Dante Rotili, Antonello Mai,
and et al. 2026. "A Combined SIRT5 Activation and SIRT3 Inhibition Prevents Breast Cancer Spheroids Growth by Reducing HIF-1α and Mitophagy" Pharmaceuticals 19, no. 1: 23.
https://doi.org/10.3390/ph19010023
APA Style
Barreca, F., Aventaggiato, M., Cristina, M., Sansone, L., Belli, M., Lista, M. B., Francisci, G., Valente, S., Rotili, D., Mai, A., Russo, M. A., & Tafani, M.
(2026). A Combined SIRT5 Activation and SIRT3 Inhibition Prevents Breast Cancer Spheroids Growth by Reducing HIF-1α and Mitophagy. Pharmaceuticals, 19(1), 23.
https://doi.org/10.3390/ph19010023
